Literature DB >> 24046065

Novel CACNA1A mutation(s) associated with slow saccade velocities.

Stefan Kipfer1, Simon Jung, Johannes R Lemke, Anna Kipfer-Kauer, Jeremy P Howell, Alain Kaelin-Lang, Thomas Nyffeler, Klemens Gutbrod, Angela Abicht, René M Müri.   

Abstract

Mutations in the voltage-gated Cav2.1 P/Q-type calcium channel (CACNA1A) can cause a wide spectrum of phenotypes, including the episodic ataxia type 2. Beside the growing number of descriptions of novel CACNA1A mutations with episodic ataxia type 2 phenotype; there are only rare reports on interictal oculomotor signs other than nystagmus. We describe a novel CACNA1A mutation and an unclassified CACNA1A in-frame variant in a Swiss family presenting as the episodic ataxia type 2 phenotype associated with reduced saccade velocity. In this case series interictal clinical examination showed only minimal neurological findings as mild limb ataxia and nystagmus, but most interestingly saccade analysis of all three affected individuals demonstrated reduced mean saccade velocity. Genetic testing of CACNA1A revealed a de novo frame-shift mutation (c.2691dupC/p.Thyr898Leufs 170) in the index patient in addition to an unclassified in-frame variant (c.6657_6659dupCCA/p.His2220dup) segregating in all three affected individuals. The de novo frame-shift CACNA1A mutation and the unclassified in-frame CACNA1A variant were associated with the episodic ataxia type 2 phenotype and reduced mean saccade velocity, which suggests involvement of brainstem or neural pathways connecting brainstem and the cerebellum in this disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24046065     DOI: 10.1007/s00415-013-7099-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

Review 1.  [Hereditary episodic ataxia].

Authors:  F Riant; K Vahedi; E Tournier-Lasserve
Journal:  Rev Neurol (Paris)       Date:  2011-04-13       Impact factor: 2.607

2.  A wide spectrum of clinical, neurophysiological and neuroradiological abnormalities in a family with a novel CACNA1A mutation.

Authors:  Romina Romaniello; Claudio Zucca; Alessandra Tonelli; Sara Bonato; Cinzia Baschirotto; Nicoletta Zanotta; Roberta Epifanio; Andrea Righini; Nereo Bresolin; Maria T Bassi; Renato Borgatti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-08       Impact factor: 10.154

3.  Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel.

Authors:  O Zhuchenko; J Bailey; P Bonnen; T Ashizawa; D W Stockton; C Amos; W B Dobyns; S H Subramony; H Y Zoghbi; C C Lee
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

4.  International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.

Authors:  P Trouillas; T Takayanagi; M Hallett; R D Currier; S H Subramony; K Wessel; A Bryer; H C Diener; S Massaquoi; C M Gomez; P Coutinho; M Ben Hamida; G Campanella; A Filla; L Schut; D Timann; J Honnorat; N Nighoghossian; B Manyam
Journal:  J Neurol Sci       Date:  1997-02-12       Impact factor: 3.181

5.  Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p.

Authors:  R W Baloh; Q Yue; J M Furman; S F Nelson
Journal:  Ann Neurol       Date:  1997-01       Impact factor: 10.422

Review 6.  Primary episodic ataxias: diagnosis, pathogenesis and treatment.

Authors:  J C Jen; T D Graves; E J Hess; M G Hanna; R C Griggs; R W Baloh
Journal:  Brain       Date:  2007-06-15       Impact factor: 13.501

Review 7.  Neurological disorders caused by inherited ion-channel mutations.

Authors:  Dimitri M Kullmann; Michael G Hanna
Journal:  Lancet Neurol       Date:  2002-07       Impact factor: 44.182

Review 8.  Episodic ataxia type 2.

Authors:  Michael Strupp; Andreas Zwergal; Thomas Brandt
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

9.  Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy.

Authors:  Sanjeev Rajakulendran; Tracey D Graves; Robyn W Labrum; Dimitrios Kotzadimitriou; Louise Eunson; Mary B Davis; Rosalyn Davies; Nicholas W Wood; Dimitri M Kullmann; Michael G Hanna; Stephanie Schorge
Journal:  J Physiol       Date:  2010-02-15       Impact factor: 5.182

Review 10.  Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in vivo.

Authors:  Susan E Tomlinson; Michael G Hanna; Dimitri M Kullmann; S Veronica Tan; David Burke
Journal:  Clin Neurophysiol       Date:  2009-09-05       Impact factor: 3.708

View more
  3 in total

Review 1.  The Clinical Spectrum of Autosomal-Dominant Episodic Ataxias.

Authors:  Stefan Kipfer; Michael Strupp
Journal:  Mov Disord Clin Pract       Date:  2014-07-28

Review 2.  The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.

Authors:  Gerald W Zamponi; Joerg Striessnig; Alexandra Koschak; Annette C Dolphin
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

3.  Ocular Manifestation of CACNA1A Pathogenic Variants.

Authors:  Karit Reinson; Katrin Õunap
Journal:  Pediatr Neurol Briefs       Date:  2016-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.